One in ten clinics in South Africa — across 22 health districts in six provinces — will start to hand out a twice-a-year anti ...

The Health departmental officials said that “a new plan will be shared" for when the funding ends in March 2026.

The country’s medicines regulator Sahpra says it’s on track to announce its registration decision by the end of October ...

Gilead has chosen a partner for lenacapavir in the race to develop new low-frequency treatments for HIV. | Gilead has chosen ...

One in 10 clinics in SA — across 22 health districts in six provinces — could start to hand out a twice-a-year anti-HIV jab ...

More than half of all new HIV diagnoses among migrants in Switzerland occur years after they have relocated, according to ...

The drug can be produced for as little as $25 per person annually, but even at $2000 per person, it can reduce new US infections almost entirely, a researcher says.

An HIV prevention jab that provides six months of protection at a time was given the green light by South Africa's medicines regulator. The approval helps to clear the way for a limited public sector ...

In the wake of massive U.S. cuts to foreign aid, the tiny country of Lesotho in southern Africa faces deep uncertainty and worry over its HIV-positive residents.

In the wake of massive U.S. cuts to foreign aid, the tiny country of Lesotho in southern Africa faces deep uncertainty and worry over its HIV-positive residents.

The Red Ribbon Club of Pranab College, in collaboration with the college Students’ Union and Department of ...